Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Midodrine · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Midodrine HCl Tablets 5 mg |
| 2 | ACTIVE_COMPARATOR | ProAmatine® Tablets 5 mg |
| Name | Type | Description |
|---|---|---|
| Midodrine HCl Tablets 5 mg | DRUG | 5mg, single dose fed |
| ProAmatine® Tablets 5 mg | DRUG | 5mg, single dose fed |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum Beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to the start of the study and the evening prior ...
Midodrine is a small molecule drug being developed by Viatris Inc. (VTRS). It is currently in Phase 1 clinical development, with studies conducted in healthy volunteers. The drug is being investigated for its effects in healthy individuals, and the development program includes three completed Phase 1 trials.
Midodrine is developed by Viatris Inc., a company traded on the stock exchange under the ticker symbol VTRS. The drug is currently in Phase 1 clinical development, with all three trials completed. These trials were conducted in the United States and enrolled a total of 97 healthy volunteers.
Midodrine is in Phase 1 clinical development. All three of its clinical trials have been completed, with a total enrollment of 97 participants. The trials were conducted in the United States and involved healthy volunteers aged 18 years and older.
Midodrine has three completed Phase 1 clinical trials: NCT00648440, a food study of Midodrine HCl Tablets 5 mg and ProAmatine Tablets 5 mg with 36 participants; NCT00650013, a fed study with 23 participants; and NCT00650364, a fasting study with 38 participants. All trials were conducted in the United States.
Midodrine is being studied in comparison to ProAmatine in clinical trials. The trials NCT00648440, NCT00650013, and NCT00650364 are food, fed, and fasting studies, respectively, that compare Midodrine HCl Tablets 5 mg with ProAmatine Tablets 5 mg in healthy volunteers.